First-level Neurocognitive Screening Tests and their Application

Journal Title: Journal of Regenerative Biology and Medicine - Year 2021, Vol 3, Issue 5

Abstract

In June 2021, the Food and Drug Administration approved Aducanumab for the treatment of Alzheimer’s disease – the most common cause of dementia worldwide [1]. This drug is a monoclonal antibody that would be cause amyloid-β plaques reduction in the brain [2]. Whether its effectiveness will be confirmed or not, the fact remains that the patients that will benefit the most from any treatment are the ones suffering from mild NCD. Mild NCD is a clinically insidious and difficult-to-diagnose disorder, and consequently, the development and the spread of screening methods are necessary to early intercept these subjects.

Authors and Affiliations

Francesco Salis*, Antonella Mandas

Keywords

Related Articles

Homologous Use of Umbilical Cord Tissue for Knee Pain

Context: Injection with homologously-used umbilical cord tissue allograft has not been adequately studied in patients suffering from knee pain. Objectives: The goal of this study is to determine if knee pain subjects...

Intra-Articular Injection of an Extracellular Vesicle Isolate Product to Treat Hip Labral Tears

Diarthrodial joints, such as the knee, hip, and shoulder consist of articular cartilage, a synovial capsule, and a fibrocartilaginous structure to increase the stability of the joint. The knee has both a medial and later...

Masitinib and its Role in Inhibiting SARS-CoV-2 Infection

A drug used successfully in veterinary medicine to treat mast cell tumors in dogs may be effective against COVID-19 and some other viral diseases in humans, according to laboratory experiments and preclinical studies pub...

Parkinson’s Disease-Overview

Parkinson’s disease one of the most complex neurological disorder. The disease risk and progression are due to common genetic variants. Approximately 6.2 million cases are reported each year according to the statistics p...

Aberfan: In memoriam

It was an ordinary day in Aberfan, Wales, and it ended in a disaster. On October 21, 1966, a 34-meter-high slag heap broke loose, slid down Mount Merthyr into the mining village and buried houses and an elementary school...

Download PDF file
  • EP ID EP707387
  • DOI https://doi.org/10.37191/Mapsci-2582-385X-3(5)-083
  • Views 65
  • Downloads 0

How To Cite

Francesco Salis*, Antonella Mandas (2021). First-level Neurocognitive Screening Tests and their Application. Journal of Regenerative Biology and Medicine, 3(5), -. https://europub.co.uk/articles/-A-707387